Fr536 EARLY ONSET OF RESPONSE WITH INTRAVENOUS VEDOLIZUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE TREATED IN THE VISIBLE 2 STUDY